Publications by authors named "Donald A Rowley"

Claim this Profile
A
Antigen-specific bacterial vaccine combined with anti-PD-L1 rescues dysfunctional endogenous T cells to reject long-established cancer.
David C Binder, Boris Engels, Ainhoa Arina, Ping Yu, James M Slauch, Donald A Rowley

Cancer Immunol Res· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relapse or eradication of cancer is predicted by peptide-major histocompatibility complex affinity.
Boris Engels, Victor H Engelhard, John Sidney, Alessandro Sette, David C Binder, Donald A Rowley

Cancer Cell· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spleen cells from young but not old immunized mice eradicate large established cancers.
Karin Schreiber, Ainhoa Arina, Boris Engels, Michael T Spiotto, John Sidney, Donald A Rowley

Clin Cancer Res· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The road to the discovery of dendritic cells, a tribute to Ralph Steinman.
Donald A Rowley, Frank W Fitch

Cell Immunol· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Densely granulated murine NK cells eradicate large solid tumors.
Rebecca B Liu, Boris Engels, Ainhoa Arina, Karin Schreiber, Elizabeth Hyjek, Donald A Rowley

Cancer Res· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A systematic analysis of experimental immunotherapies on tumors differing in size and duration of growth.
Frank T Wen, Ronald A Thisted, Donald A Rowley, Hans Schreiber

Oncoimmunology· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting stroma to treat cancers.
Boris Engels, Donald A Rowley, Hans Schreiber

Semin Cancer Biol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting mutations predictably.
Hans Schreiber, Janet D Rowley, Donald A Rowley

Blood· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevention of renal allograft rejection without immune suppression: a model to revisit.
Donald A Rowley, Frank P Stuart, Frank W Fitch

Clin Transplant· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progression of cancer from indolent to aggressive despite antigen retention and increased expression of interferon-gamma inducible genes.
Terry H Wu, Karin Schreiber, Ainhoa Arina, Nikolai N Khodarev, Elena V Efimova, Donald A Rowley

Cancer Immun· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer. Awakening immunity.
Hans Schreiber, Donald A Rowley

Science· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IFN-gamma- and TNF-dependent bystander eradication of antigen-loss variants in established mouse cancers.
Bin Zhang, Theodore Karrison, Donald A Rowley, Hans Schreiber

J Clin Invest· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Equilibrium between host and cancer caused by effector T cells killing tumor stroma.
Bin Zhang, Yi Zhang, Natalie A Bowerman, Andrea Schietinger, Yang-Xin Fu, Donald A Rowley

Cancer Res· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer. Quo vadis, specificity?
Hans Schreiber, Donald A Rowley

Science· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induced sensitization of tumor stroma leads to eradication of established cancer by T cells.
Bin Zhang, Natalie A Bowerman, Joseph K Salama, Hank Schmidt, Michael T Spiotto, Donald A Rowley

J Exp Med· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer immunotherapy and preclinical studies: why we are not wasting our time with animal experiments.
Karin Schreiber, Donald A Rowley, Gert Riethmüller, Hans Schreiber

Hematol Oncol Clin North Am· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of stroma in immune recognition and destruction of well-established solid tumors.
Ping Yu, Donald A Rowley, Yang-Xin Fu, Hans Schreiber

Curr Opin Immunol· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammation as a tumor promoter in cancer induction.
Mary Philip, Donald A Rowley, Hans Schreiber

Semin Cancer Biol· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bystander elimination of antigen loss variants in established tumors.
Michael T Spiotto, Donald A Rowley, Hans Schreiber

Nat Med· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
C-kit+ FcR+ myelocytes are increased in cancer and prevent the proliferation of fully cytolytic T cells in the presence of immune serum.
Christian Beck, Karin Schreiber, Hans Schreiber, Donald A Rowley

Eur J Immunol· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increasing tumor antigen expression overcomes "ignorance" to solid tumors via crosspresentation by bone marrow-derived stromal cells.
Michael T Spiotto, Ping Yu, Donald A Rowley, Michael I Nishimura, Stephen C Meredith

Immunity· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis